Team

Joshua completed his PhD in Biomedical Engineering at Arizona State University, where he developed leukocyte-mimetic contrast agents to map and quantify spatiotemporal dynamics of vascular inflammation. As a postdoc, he now investigates DNA lipid nanoparticles (DNA-LNPs) as a platform for targeted and sustained therapeutic treatment of chronic cardiovascular and cerebrovascular diseases.